IDXG
Price:
$2.84
Market Cap:
$12.51M
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a geno...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1998-05-20
Stock Exchange
PNK
Ticker
IDXG
According to Interpace Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.59M. This represents a change of 4.84% compared to the average of 11.05M of the last 4 quarters.
The mean historical Enterprise Value of Interpace Biosciences, Inc. over the last ten years is 17.80M. The current 11.59M Enterprise Value has changed 6.41% with respect to the historical average. Over the past ten years (40 quarters), IDXG's Enterprise Value was at its highest in in the June 2021 quarter at 50.26M. The Enterprise Value was at its lowest in in the June 2017 quarter at -5694952.14.
Average
17.80M
Median
15.48M
Minimum
840.18K
Maximum
41.29M
Discovering the peaks and valleys of Interpace Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.86%
Maximum Annual Enterprise Value = 41.29M
Minimum Annual Increase = -95.36%
Minimum Annual Enterprise Value = 840.18K
Year | Enterprise Value | Change |
---|---|---|
2023 | 12.36M | -21.15% |
2022 | 15.67M | -62.05% |
2021 | 41.29M | 182.37% |
2020 | 14.62M | -37.79% |
2019 | 23.50M | 42.80% |
2018 | 16.46M | 1.86% |
2017 | 840.18K | -94.51% |
2016 | 15.30M | 110.03% |
2015 | 7.28M | -76.29% |
2014 | 30.72M | -95.36% |
The current Enterprise Value of Interpace Biosciences, Inc. (IDXG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
23.11M
5-year avg
21.49M
10-year avg
17.80M
Interpace Biosciences, Inc.’s Enterprise Value is greater than Intelligent Bio Solutions Inc. (2.52M), less than bioAffinity Technologies, Inc. (16.44M), less than SeqLL Inc. (81.77M), greater than Biocept, Inc. (-788000.00), less than FONAR Corporation (81.93M), less than Burning Rock Biotech Limited (81.51M), less than Sera Prognostics, Inc. (286.44M), less than Olink Holding AB (publ) (3.16B), less than LumiraDx Limited (301.24M), greater than HTG Molecular Diagnostics, Inc. (443.00), less than bioAffinity Technologies, Inc. (16.44M), greater than Genetron Holdings Limited (0), less than Exagen Inc. (92.07M), less than OncoCyte Corporation (37.50M), less than Personalis, Inc. (375.58M), greater than iSpecimen Inc. (2.32M), less than Trinity Biotech plc (103.28M),
Company | Enterprise Value | Market cap |
---|---|---|
2.52M | $5.70M | |
16.44M | $15.47M | |
81.77M | $0 | |
-788000.00 | $0 | |
81.93M | $94.95M | |
81.51M | $65.57M | |
286.44M | $288.03M | |
3.16B | $3.24B | |
301.24M | $0 | |
443.00 | $1.06M | |
16.44M | $4.68M | |
0 | $127.29M | |
92.07M | $90.83M | |
37.50M | $36.87M | |
375.58M | $406.23M | |
2.32M | $2.89M | |
103.28M | $9.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Interpace Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Interpace Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Interpace Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Interpace Biosciences, Inc. (IDXG)?
What is the 3-year average Enterprise Value for Interpace Biosciences, Inc. (IDXG)?
What is the 5-year average Enterprise Value for Interpace Biosciences, Inc. (IDXG)?
How does the current Enterprise Value for Interpace Biosciences, Inc. (IDXG) compare to its historical average?